Health Care Fraud – Investigations + Litigation

Second Circuit Delivers Blow to Off-Label Promotion Prosecutions in U.S. v. Caronia

Adam Hoffinger, Robert Salerno, and Demme Doufekias

12/5/2012

Health Care Fraud – Investigations + Litigation, Life Sciences, Pharmaceutical + Medical Device, White-Collar Defense

Client Alert

Physician Payment Sunshine Act: Challenge for Companies, Tool for Enforcers

Adam Hoffinger, Robert Salerno, and Demme Doufekias

10/19/2012

Health Care Fraud – Investigations + Litigation, Life Sciences, Pharmaceutical + Medical Device, White-Collar Defense

Client Alert

CMS Issues Proposed Rule for Reporting and Returning Overpayments to Medicare

2/23/2012

False Claims Act, Health Care Fraud – Investigations + Litigation

Client Alert

DOJ Escalates Its War on Health Care Fraud:
GlaxoSmithKline Agrees to Pay Record-setting $3 Billion to Settle U.S. Investigations

Adam Hoffinger, Robert Salerno, and Demme Doufekias

11/4/2011

False Claims Act, Health Care Fraud – Investigations + Litigation, Life Sciences, Securities Litigation, Enforcement + White-Collar Defense, White-Collar Defense

Client Alert

The Physician Payments Sunshine Act:
Little Guidance, But Many Potential Risks

Adam Hoffinger and Demme Doufekias

10/19/2011

False Claims Act, Health Care Fraud – Investigations + Litigation, Life Sciences, Pharmaceutical + Medical Device, Product Liability

Client Alert

Fighting Off-Label Qui Tam Suits: Have Federal Courts Encouraged Filing of Speculative FCA Claims?

Legal Backgrounder, Vol. 25 No. 14, Washington Legal Foundation

Robert Salerno and Demme Doufekias

4/23/2010

Health Care Fraud – Investigations + Litigation, Life Sciences, Litigation, Securities Litigation, Enforcement + White-Collar Defense

Article

Reprinted with permission of Washington Legal Foundation

Loading...

Loading...